Bide Pharmatech Co (SHSE:688073) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688073 Bide Pharmatech Co Ltd SHSE:688073
89 GF Score
Price ¥81.84
GF Value ¥67.90
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Bide Pharmatech Co Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Bide Pharmatech Co Quality Rank Related Terms

SHSE:688073
89GF Score
Bide Pharmatech Co Ltd SHSE:688073
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bide Pharmatech Co (SHSE:688073) Overvalued in 2026?

Based on GuruFocus' analysis, Bide Pharmatech Co stock appears to be overvalued. The current stock price of ¥81.84 is trading 20.5% above its estimated GF Value™ of ¥67.90. GuruFocus considers Bide Pharmatech Co to be Modestly Overvalued.

Key valuation signals for SHSE:688073:

  • Quality Rank:
  • GF Value™: ¥67.90 vs. price of ¥81.84 (20.5% above fair value)
  • GF Score™: 89/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688073 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bide Pharmatech Co Business Description

Address No. 128, Xiangyin Road, Room 101, Block A, Building 11, Yangpu District, Shanghai, CHN, 200433
Bide Pharmatech Co Ltd is engaged in the research and development, design, production and sales of drug molecular building blocks.
89GF Score

Get the complete analysis for SHSE:688073

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥81.84
Price
¥67.90
GF Value